Silicon Valley Bank

Plus: Northcott to lead commercial at Nurix, Bach joins Limani Partners and updates from the National MS Society, Octopus and Neurocrine

Overwhelming majority of biotechs expect pipeline setbacks; many oppose BIO’s reversal 

Plus: Cargo hires Laport as CMO and updates from SVB and Genascence

Building ties across stakeholders has been key to helping U.K. biotech avert disasters for the ecosystem while fostering growth

Plus: Beam moves base editors into the clinic and updates on Star, Tivdak, Olema and Insmed’s Arikayce 

Plus: SVB bolsters its life science and healthcare sector with two new appointments, and updates from Concerto and Annexon

Charting the course for Leerink Partners out of SVB’s ashes

Key will be diversified, gradual deployment of capital into unlisted equities

Important financing partner regains its independence via management buyout of SVB Securities 

Plus: a conversation with Forbion, and why Senate Democrats are holding up confirmation of a new NIH director